- Home
- GOSS vs KNOP Comparison
GOSS vs KNOP Comparison
Compare GOSS & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- KNOP
- Stock Information
- Founded
- GOSS 2015
- KNOP 2013
- Country
- GOSS United States
- KNOP United Kingdom
- Employees
- GOSS N/A
- KNOP N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- KNOP Marine Transportation
- Sector
- GOSS Health Care
- KNOP Consumer Discretionary
- Exchange
- GOSS Nasdaq
- KNOP Nasdaq
- Market Cap
- GOSS 212.9M
- KNOP 213.1M
- IPO Year
- GOSS 2019
- KNOP 2013
- Fundamental
- Price
- GOSS $0.81
- KNOP $5.37
- Analyst Decision
- GOSS Strong Buy
- KNOP
- Analyst Count
- GOSS 5
- KNOP 0
- Target Price
- GOSS $9.20
- KNOP N/A
- AVG Volume (30 Days)
- GOSS 2.3M
- KNOP 115.0K
- Earning Date
- GOSS 11-07-2024
- KNOP 12-04-2024
- Dividend Yield
- GOSS N/A
- KNOP 1.93%
- EPS Growth
- GOSS N/A
- KNOP N/A
- EPS
- GOSS N/A
- KNOP N/A
- Revenue
- GOSS $105,322,000.00
- KNOP $299,790,000.00
- Revenue This Year
- GOSS N/A
- KNOP $7.66
- Revenue Next Year
- GOSS N/A
- KNOP $1.75
- P/E Ratio
- GOSS N/A
- KNOP N/A
- Revenue Growth
- GOSS N/A
- KNOP 4.75
- 52 Week Low
- GOSS $0.50
- KNOP $4.94
- 52 Week High
- GOSS $1.60
- KNOP $9.11
- Technical
- Relative Strength Index (RSI)
- GOSS 49.87
- KNOP 28.77
- Support Level
- GOSS $0.76
- KNOP $5.28
- Resistance Level
- GOSS $0.88
- KNOP $5.98
- Average True Range (ATR)
- GOSS 0.08
- KNOP 0.23
- MACD
- GOSS 0.01
- KNOP -0.03
- Stochastic Oscillator
- GOSS 30.48
- KNOP 8.52
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.